$3.270
-0.020 (-0.61%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
RLMD Prediction & Forecast by Similar Chart Analysis
Alphio's RLMD stock price prediction model matches the current Relmada Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.50 (+7.13%). The 1-week path is $3.72 (+13.82%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Relmada Therapeutics Inc Stock?
Relmada Therapeutics Inc (RLMD) is a good buy right now due to its current price of $3.27, which is significantly lower than the analyst price target of $12, indicating a potential upside of over 267%. Additionally, the stock's RSI is currently at 46.8, suggesting it is neither overbought nor oversold, which is favorable for new investors. The recent insider buying activity, with the CFO purchasing 200,000 shares at $4.22, reflects confidence in the company's future performance. However, the main risk is the company's negative earnings, with a projected EPS of -0.32 for Q2 2026, indicating ongoing financial challenges.
RLMD stock price ended at $3.27 on Friday, after losing -0.61%
Relmada Therapeutics Inc (RLMD) last closed at $3.27, losing -0.61%. These facts feed the 1-day and 1-week RLMD price prediction above.
Forecast Drivers
Relmada Therapeutics Inc (RLMD) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches RLMD, ranked by similarity.
Seasonality analysis for RLMD
Historically the probability of a positive October return for RLMD is 36.51%. June offers the highest probability of a positive month at 68.33%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for RLMD
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $0.43 | $0.51 | $0.60 | -84.25% |
| Nov 2026 | $0.59 | $0.65 | $0.75 | -80.25% |
| Dec 2026 | $0.68 | $0.69 | $0.76 | -78.80% |
In 2026, Relmada Therapeutics Inc (RLMD) is projected to range from $0.43 to $0.76.
Relmada Therapeutics Inc 2026 monthly forecast
In Oct 2026, Relmada Therapeutics Inc is projected to average $0.51, with a low of $0.43 and high of $0.60.
In Nov 2026, Relmada Therapeutics Inc is projected to average $0.65, with a low of $0.59 and high of $0.75.
In Dec 2026, Relmada Therapeutics Inc is projected to average $0.69, with a low of $0.68 and high of $0.76.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.